CFGS
BEAT

Concourse Financial Group Securities’s BioTelemetry, Inc. BEAT Stock Holding History

Concourse Financial Group Securities’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-82
Closed -$4.29K – 2416
2020
Q3 		$4K Hold
82
– – ﹤0.01% 1916
2020
Q2 		$4K Sell
82
-31
-27% -$1.39K ﹤0.01% 1797
2020
Q1 		$4K Buy
+113
New +$5.2K ﹤0.01% 1771
2019
Q2 		– Sell
-68
Closed -$3.58K – 2488
2019
Q1 		$4K Sell
68
-84
-55% -$5.77K ﹤0.01% 1880
2018
Q4 		$9K Sell
152
-4
-3% -$240 ﹤0.01% 1481
2018
Q3 		$10K Buy
+156
New +$8.71K ﹤0.01% 1127

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Concourse Financial Group Securities's BEAT Position: Q4 2020 in Review

Concourse Financial Group Securities sold out of BioTelemetry, Inc. (BEAT) in Q4 2020, closing a stake of 82 shares — an estimated $4.29K sold.

Concourse Financial Group Securities first reported a position in BEAT in Q3 2018 and held it in 6 quarters. The position peaked at $10K in Q3 2018. 238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.

  • Concourse Financial Group Securities reported no remaining BioTelemetry, Inc. position as of Q4 2020 after selling out during the quarter.
  • Concourse Financial Group Securities sold 82 BioTelemetry, Inc. shares in Q4 2020, an estimated $4.29K.
  • Concourse Financial Group Securities first reported a position in BioTelemetry, Inc. in Q3 2018 and held it in 6 quarters.
  • Concourse Financial Group Securities's BioTelemetry, Inc. position peaked at $10K in Q3 2018.
  • 238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.

Based on Concourse Financial Group Securities's 13F filing for Q4 2020, filed 2 Feb 2021.